Work

P79.04 A Phase 2 Trial of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis.

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.1183

Authors: D. Owen, L. Wei, C. Pilcher, S. Patel, B. Konda, M. Shah, S. Ferguson, B. Benner, R. Norman, W. Carson, M. Smith, S. Mori Vogt, C. Verschraegen, K. He, E. Bertino, C. Presley, P. Shields, D. Carbone, G. Otterson

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3137905056

Cites:

Cited by:

Related to: 10